The company is not selling any securities under this prospectus and will not receive any of the proceeds from the sale of our common shares by the selling shareholder, Armistice Capital Master Fund.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDCX:
- Is MDCX a Buy, Before Earnings?
- Optimistic Buy Rating for Medicus Pharma Ltd Driven by Promising SkinJect Developments and Strategic Initiatives
- Medicus Pharma Seeks FDA Priority Voucher for Innovative Skin Cancer Treatment
- Medicus Pharma announces filing of CNPV application for SKNJCT-003
- Medicus Pharma Reports Q3 Loss Amid Strategic Growth